D-Index & Metrics Best Publications

Stefanie Dimmeler

Goethe University Frankfurt
Germany

Medicine

Germany

2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 167 Citations 108,342 715 World Ranking 326 National Ranking 12

Best female scientists D-index 171 Citations 111,465 740 World Ranking 41 National Ranking 2

Best Scientists D-index 171 Citations 111,465 740 World Ranking 571 National Ranking 21

Research.com Recognitions

Awards & Achievements

2023 - Research.com Best Female Scientist Award

2023 - Research.com Best Scientist Award

2023 - Research.com Medicine in Germany Leader Award

2022 - Research.com Best Female Scientist Award

2022 - Research.com Best Scientist Award

2017 - German National Academy of Sciences Leopoldina - Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften Internal Medicine and Dermatology

Member of the European Molecular Biology Organization (EMBO)

Overview

What is she best known for?

The fields of study Stefanie Dimmeler is best known for:

Enzyme
Myocardial infarction
Heart failure

In her works, Stefanie Dimmeler conducts interdisciplinary research on Enzyme and Nitric oxide. Stefanie Dimmeler connects Nitric oxide with Enzyme in her study. Her work on Phosphate expands to the thematically related Organic chemistry. As part of her studies on Phosphate, she frequently links adjacent subjects like Organic chemistry. Her study on Glyceraldehyde is mostly dedicated to connecting different topics, such as Dehydrogenase. Her Dehydrogenase study often links to related topics such as Glyceraldehyde. She frequently studies issues relating to Glyceraldehyde 3-phosphate dehydrogenase and Biochemistry. Her research ties Biochemistry and Glyceraldehyde 3-phosphate dehydrogenase together. By researching both Biotechnology and Genetics, Stefanie Dimmeler produces research that crosses academic boundaries.

Her most cited work include:

Infarct Remodeling After Intracoronary Progenitor Cell Treatment in Patients With Acute Myocardial Infarction (TOPCARE-AMI) (545 citations)
Nitric oxide causes ADP-ribosylation and inhibition of glyceraldehyde-3-phosphate dehydrogenase. (264 citations)

What are the main themes of her work throughout her whole career to date

Glyceraldehyde 3-phosphate dehydrogenase and Glyceraldehyde are inherently bound to her Dehydrogenase studies. Her work in Glyceraldehyde 3-phosphate dehydrogenase is not limited to one particular discipline; it also encompasses Dehydrogenase. Her studies link Transplantation with Internal medicine. In most of her Transplantation studies, her work intersects topics such as Internal medicine. Her Biochemistry study often links to related topics such as Enzyme assay. Her Genetics study frequently draws connections to adjacent fields such as Vitality. In most of her Vitality studies, her work intersects topics such as Genetics. In her works, Stefanie Dimmeler conducts interdisciplinary research on Cardiology and Gastroenterology. She integrates Gastroenterology with Cardiology in her study.

Stefanie Dimmeler most often published in these fields:

Internal medicine (60.00%)
Biochemistry (50.00%)
Genetics (50.00%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

Stefanie Dimmeler;Ingrid Fleming;Beate Fisslthaler;Corinna Hermann.
Nature (1999)

4233 Citations

Endothelial Progenitor Cells: Characterization and Role in Vascular Biology

Carmen Urbich;Stefanie Dimmeler.
Circulation Research (2004)

3702 Citations

Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease

Mariuca Vasa;Stephan Fichtlscherer;Alexandra Aicher;Klaudia Adler.
Circulation Research (2001)

3590 Citations

Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)

Birgit Assmus;Volker Schächinger;Claudius Teupe;Martina Britten.
Circulation (2002)

3188 Citations

Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

Volker Schächinger;Sandra Erbs;Albrecht Elsässer;Werner Haberbosch.
The New England Journal of Medicine (2006)

2362 Citations

HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway

Stefanie Dimmeler;Alexandra Aicher;Mariuca Vasa;Christiane Mildner-Rihm.
Journal of Clinical Investigation (2001)

1752 Citations

Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial.

Volker Schächinger;Birgit Assmus;Martina B. Britten;Jörg Honold.
Journal of the American College of Cardiology (2004)

1700 Citations

Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular Events Proof of Concept for the Clinical Importance of Endogenous Vascular Repair

Caroline Schmidt-Lucke;Lothar Rössig;Stephan Fichtlscherer;Mariuca Vasa.
Circulation (2005)

1555 Citations

Transcoronary transplantation of progenitor cells after myocardial infarction.

Birgit Assmus;Jörg Honold;Volker Schächinger;Martina B Britten.
The New England Journal of Medicine (2006)

1542 Citations

Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable Coronary Artery Disease

Mariuca Vasa;Stephan Fichtlscherer;Klaudia Adler;Alexandra Aicher.
Circulation (2001)

1526 Citations

If you think any of the details on this page are incorrect, let us know.